NeutraKine® IL-3 Monoclonal antibody
NeutraKine® IL-3 Monoclonal Antibody for Neutralization,ELISA
Host / Isotype
Mouse / IgG1
Cat no : 69004-1-Ig
|Neutralization||Measured by its ability to neutralize Human IL-3 induced proliferation of TF-1 cell line (human erythroleukemic cell line). The half neutralization dose (ND50) is typically 0.8-2.4 ng/mL in the presence of 0.5 ng/mL Human IL-3.|
69004-1-Ig targets NeutraKine® IL-3 in Neutralization,ELISA applications and shows reactivity with Human samples.
|Host / Isotype||Mouse / IgG1|
|Immunogen||human NeutraKine® IL-3 protein HZ-1074|
|Full Name||interleukin 3 (colony-stimulating factor, multiple)|
|Gene ID (NCBI)||3562|
|Purification Method||Protein G purification|
|Storage Buffer||Sterile PBS.|
|Reconstitution||This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.|
|Stability and Storage||Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.|
Interleukin-3 (IL-3) is a multilineage hematopoietic growth factor that promotes the proliferation, differentiation and survival of early multilineage hematopoietic progenitors. In particular, this cytokine plays a key role in stimulating the proliferation and survival of myeloid precursors. It is involved in a variety of cell activities such as cell growth, differentiation and apoptosis. This cytokine has been shown to also possess neurotrophic activity, and it may be associated with neurologic disorders (PMID: 24103757;2698876;2809196).
This antibody is used to Block/Neutralize IL3 protein.